PATHOLOGY OF GLOMERULAR MATRIX METABOLISM
PATHOLOGY OF GLOMERULAR MATRIX METABOLISM
批准号:
2684182
负责人:
DAVID H LOVETT
金额:
$27.48万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 2001-03-31
关键词:
DNA footprinting binding proteins enzyme mechanism genetic enhancer element genetic transcription glomerulosclerosis high performance liquid chromatography immunopathology inflammation kidney cell kidney metabolism laboratory rat molecular cloning phenotype polymerase chain reaction protein structure function receptor expression stromelysin tissue /cell culture transfection
中文摘要
进行性肾小球硬化导致终末期肾衰竭是一种
大多数形式的慢性肾小球疾病的统一特征,
大量的文献记载了
在复杂的生物事件中,
scoping过程。 该实验室重点研究了
特异性基质金属蛋白酶,即72 kDa明胶酶A(也表示为
基质金属蛋白酶2(MMP-2)在肾小球损伤中的作用。
当正常静止和非增殖时,系膜细胞获得
在炎症状态期间(和培养中),
这些特征可被定义为“炎性表型”。“那
这种炎性表型的获得与高表达直接相关。
MMP-2的水平合成。 在最近的研究中,
我们的研究表明,MMP-2直接作用于细胞的合成,
细胞,是至关重要的发展和维护的
炎症表型 因此,我们研究的基本假设是
MMP-2的持续性系膜合成是肾小球硬化的共同特征。
对炎症损伤的反应,这有助于向
scandy州。 考虑到拟议的MMP-2在
发展的系膜炎性表型,更深入的了解
事实上,s调控MMP-2的高水平合成及其机制
由此该酶与肾小球系膜细胞相互作用是必要的。 在这
关于这一点,系膜细胞对MM β-2合成的转录调节是通过细胞外基质介导的。
细胞是独特的,我们已经能够确定一个强大的系膜细胞,
可能决定高水平表达的细胞特异性增强子元件
MMP-2的炎症表型特征。 第二,证据
从这个实验室和其他实验室收集的数据表明,
存在质膜MMP-2结合蛋白,其可能控制细胞的增殖。
酶与周围细胞外基质的相互作用。 这些
这些观察为以下具体目标提供了基础
建议:1.目的:克隆肾小球系膜细胞特异性基质金属蛋白酶-2(MMP-2),
结合蛋白,其调节酶与
周围细胞外基质;和2. 表征
转录调控机制参与控制高水平的
系膜细胞合成MMP-2代表炎症
表型 拟议的研究在方法上是互补的,
系膜细胞MMP-2转录调控的问题
在炎性表型的背景下,
这种酶通过特定的膜调节系膜细胞的行为
交互.
英文摘要
Progressive glomerulosclerosis leading to end stage renal failure is a
unifying feature of most forms of chronic glomerular disease, and an
extensive body of literature has documented the central role of the
intrinsic mesangial cell in the complex biologic events which characterize
the sclerotic process. This laboratory has focused on the role of a
specific matrix metalloproteinase, the 72 kDa gelatinase A (also denoted
matrix metalloproteinase 2, MMP-2) ina the evolution of glomerular injury.
While normally quiescent and non-proliferative, the mesangial cell acquires
during inflammatory states (and in cultaure) a characteristic spectrum of
features which may be defined as the "inflammatory phenotype." The
acquisition of this inflammatory phenotype is directly coupled with high
level synthesis of MMP-2. In recent studies outlined in detail in this
proposal, we demonstrated that MMP-2 acts directly upon the synthesizing
cells and is critical for the development and maintenance of the
inflammatory phenotype. Thus, the fundamental hypothesis of our studies is
that persistent mesangial synthesis of MMP-2 is a common feature of the
response to inflammatory injury which facilitates the evolution to the
sclerotic state. Given the central role proposed for MMP-2 int he
development of the mesangial inflammatory phenotype, a deeper understanding
of the factos controlling high level MMP-2 synthesis and the mechanisms
whereby this enzyme interacts with mesangial cells is warranted. In this
regard, the transcriptional regulation of MM{P-2 synthesis by mesangial
cells is distinctive and we have been able to identify a strong mesangial
cell-specific enhancer element which may dictate the high level expression
of MMP-2 characteristic of the inflammatory phenotype. Secondly, evidence
gathered from this and other laboratories has indicated that specific
plasma membrane MMP-2 binding proteins exist, which may control the
interaction of the enzyme with the surrounding extracellular matrix. These
observations provide the basis for the following Specific Aims of this
proposal: 1. To clone and characterize the specific mesangial cell MMP-2
binding protein which regulates the interaction of the enzyme with the
surrounding extracellular matrix; and 2. to characterize the
transcriptional regulatory mechanisms involved in the control of high level
mesangial cell synthesis of MMP-2 representative of the inflammatory
phenotype. The proposed studies are complementary in approach, dealing
with the issue of MMP-2 transcriptional regulation by mesangial cells
within the context of the inflammatory phenotype and the means by which
this enzyme modulates mesangial cellular behavior through specific membrane
interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Matrix Metalloproteinase-2 and Cardiac Injury
-
批准号:8195892
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H LOVETT
-
依托单位:
Mitochondrial Matrix Metalloproteinase-2 and Cardiac Injury
-
批准号:7797295
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H LOVETT
-
依托单位:
Mitochondrial Matrix Metalloproteinase-2 and Cardiac Injury
-
批准号:7904116
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H LOVETT
-
依托单位:
Mitochondrial Matrix Metalloproteinase-2 and Cardiac Injury
-
批准号:8597347
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID H LOVETT
-
依托单位:
Pathobiology of Renal Matrix Metabolism
-
批准号:7031422
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2005
-
负责人:DAVID H LOVETT
-
依托单位:
Matrix metalloproteinase-2 & progressive cardiac fibrosi
-
批准号:6652376
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2002
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:6327467
-
项目类别:
-
资助金额:$33.15万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:6517147
-
项目类别:
-
资助金额:$34.14万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
GROWTH FACTORS AND MESANGIAL MATRIX METABOLISM
-
批准号:3239740
-
项目类别:
-
资助金额:$17.2万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOBIOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:3239741
-
项目类别:
-
资助金额:$17.64万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:2391407
-
项目类别:
-
资助金额:$26.72万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOBIOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:2141057
-
项目类别:
-
资助金额:$6.36万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
GROWTH FACTORS AND MESANGIAL MATRIX METABOLISM
-
批准号:3239737
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:6729193
-
项目类别:
-
资助金额:$40.11万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:7192529
-
项目类别:
-
资助金额:$32.84万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:6177031
-
项目类别:
-
资助金额:$29.1万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOBIOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:3239743
-
项目类别:
-
资助金额:$19.09万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:7541736
-
项目类别:
-
资助金额:$32.19万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
PATHOBIOLOGY OF GLOMERULAR MATRIX METABOLISM
-
批准号:3239738
-
项目类别:
-
资助金额:$17.95万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
Pathology of Renal Matrix Metabolism
-
批准号:7030705
-
项目类别:
-
资助金额:$33.83万
-
财政年份:1987
-
负责人:DAVID H LOVETT
-
依托单位:
海外基金